Tonix Pharmaceuticals Holding Corp (TNXP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.43
• Market Cap: $190.19M
• P/E Ratio: 0.06
• EPS: $279.15
• 52-Week High: $69.97
• 52-Week Low: $6.76

Market Sentiment

Tonix Pharmaceuticals Holding Corp currently has a Bullish sentiment score of 0.15.

About Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biopharmaceutical company based in Chatham, New Jersey, specializing in the development of innovative therapies for central nervous system disorders and rare diseases. The company is committed to addressing unmet medical needs, particularly in the domains of mental health and pain management, and is advancing a strong pipeline of proprietary drug candidates through various stages of clinical trials. Tonix's expertise in drug formulation and deli...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tonix Pharmaceuticals Holding Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TNXP pay dividends?

Tonix Pharmaceuticals Holding Corp (TNXP) does not currently pay a regular dividend.

What is TNXP's P/E ratio?

Tonix Pharmaceuticals Holding Corp has a price-to-earnings (P/E) ratio of 0.06.

What is TNXP's market cap?

Tonix Pharmaceuticals Holding Corp (TNXP) has a market capitalization of $190.19M with a current stock price of $14.43.